Choose category
Your Cart

Buy Retatrutide 10mg | DEUSPOWER

RETATRUTIDE 10mg (GLP-1, GIP & Glucagon Triple Receptor Agonist), Deus Medical, Buy Peptides Online – www.deuspower.shop
RETATRUTIDE 10mg (GLP-1, GIP & Glucagon Triple Receptor Agonist), Deus Medical, Buy Peptides Online – www.deuspower.shop
New
RETATRUTIDE 10mg (GLP-1, GIP & Glucagon Triple Receptor Agonist), Deus Medical, Buy Peptides Online – www.deuspower.shop
RETATRUTIDE 10mg (GLP-1, GIP & Glucagon Triple Receptor Agonist), Deus Medical, Buy Peptides Online – www.deuspower.shop
Shipping methods (7–28 business days)
• EU shipping is 22 EUR for Deus Medical
• Outside EU shipping is 28 EUR for Deus Medical
• United States shipping is 30 EUR for Deus Medical
• EU shipping is 22 EUR for Astera Labs
• Outside EU shipping is 28 EUR for Astera Labs
• United States shipping is 30 EUR for Astera Labs
• EU shipping is 8 EUR for Biaxol
• Outside EU shipping is 15 EUR for Biaxol
Support
info@deuspower.info 

Write to us for more information about this product.

Payment methods
• Bank transfer
• Bitcoin
• USDT (TRC20)
• USDC (ERC20)
Buy Retatrutide 10mg | DEUSPOWER
  • Stock: IN STOCK
  • Brand: DEUS MEDICAL
  • Reward Points: RECEIVE 20 REWARD POINTS
  • Model: RETATRUTIDE
  • Review count: 8 , Add testimonial
  • Average rating: 5
90.00€
Price in reward points: 355

RETATRUTIDE 10mg (GLP‑1, GIP & Glucagon Triple Receptor Agonist) - Lyophilised Peptide Vial

PRODUCT OVERVIEW

RETATRUTIDE 10mg is a lyophilised peptide vial that functions as a triple receptor agonist. It targets three separate pathways: GLP-1 (Glucagon-like peptide-1), GIP (Glucose-dependent insulinotropic polypeptide), and glucagon. This multi-pathway approach supports insulin secretion, helps manage blood glucose levels, curbs appetite and craving pangs, and increases metabolism. It is ideal for structured programmes regarding body composition and glucose control. If you're looking for Retatrutide online sale options, Deus Medical vials come with clear labelling and batch documentation. The lyophilised format is practical because after reconstitution, you can adjust the concentration to fit your specific needs and dosing schedules. 

KEY FEATURES

  • Form: Lyophilised peptide powder in a sterile vial
  • Active Compound: Retatrutide (triple receptor agonist)
  • Receptor Profile: GLP‑1, GIP, and glucagon receptor agonist
  • Concentration: 10 mg total peptide content per vial
  • Brand: Deus Medical
  • Package Content: 1 box containing 1 vial (10 mg total)
  • Also Known As: Retatrutide (GLP‑1 / GIP / Glucagon triple agonist, 10mg/vial)

BENEFITS

  • Triple-Pathway Design: Allows research into combined GLP‑1, GIP, and glucagon receptor activation within a single peptide structure.
  • Weekly-Orientated Pharmacokinetics: Approximate seven‑day half-life supports once-weekly protocol design.
  • Flexible Dosing Set-up: 10 mg vial format permits preparation of customised concentrations after reconstitution, depending on study needs.
  • Research Alignment: Suitable for projects exploring body weight regulation and appetite signalling under controlled conditions.

USAGE INSTRUCTIONS

  • Reconstitution: RETATRUTIDE 10mg is supplied as a lyophilised peptide and must be reconstituted with a suitable sterile diluent (such as bacteriostatic water) before use. For guidance on reconstitution technique, refer to the DeusPower Peptide Reconstitution Guide.
  • Dosing Framework (label-based):The label indicates a 10 mg/vial triple receptor agonist with a blood half-life of approximately 7 days, suitable for weekly administration in research protocols. Common research starting ranges are 0.25–0.5 mg per week, with gradual adjustments every 3–4 weeks depending on tolerance and study design. Reported typical ranges fall between 2–8 mg per week within research-only settings.
  • Titration & Scheduling: Programmes often begin at the lower end of the range and increase stepwise to observe response over time. Once-weekly administration is usually sufficient within a given protocol.

IMPORTANT INFORMATION

  • Consult a Professional: Health guidance is advised before use, especially for those who may have cardiovascular conditions or other underlying health concerns.
  • Not Recommended: Strictly not for pregnant/breastfeeding women or those under 18.
  • Dosage Caution: Do not exceed the maximum daily dosages mentioned above.
  • Duration: Do not use for more than 12 weeks to ensure the body's cardiovascular and other systems receive adequate rest.

STORAGE

  • Store below 30°C. Protect from light. Do not freeze. Keep out of reach of children.

LEGAL DISCLAIMER

This product is intended for use only in accordance with applicable laws and regulations. The information provided is for educational purposes and does not replace medical advice. Misuse may involve health risks. Seek professional guidance where appropriate.


WHY CHOOSE OUR RETATRUTIDE 10mg VIAL?

  • Defined content per vial: Each Deus Medical vial contains 10 mg of retatrutide, with batch and content clearly printed on the label to support traceability in documented research projects.
  • Structured research focus: The triple receptor agonist profile makes this vial suitable for studies comparing single‑pathway compounds with multi‑pathway alternatives, especially for groups seeking retatrutide online sale options with reliable documentation.
  • Presentation and practicality: The lyophilised format gives you flexibility. You can choose your own reconstitution volume and concentration, which means you can align the peptide solution with whatever protocols you're already running.
  • Brand consistency: Deus Medical has a solid track record in the peptide space on Deuspower. The packaging, labelling, and product categorisation stay consistent across their compounds, so managing inventory across multiple peptides is straightforward.

FAQ

RETATRUTIDE 10mg is positioned as a triple receptor agonist peptide used within structured programmes that focus on body weight and glucose‑control goals. It is most often discussed in the context of appetite management and long-term weight control approaches. The key point is scope: it's presented as a "multi‑target" option rather than a single‑pathway peptide. As always, the practical value depends on how clearly the programme is planned and monitored.
RETATRUTIDE 10mg works differently than hormone products. It's a peptide that interacts with three receptor targets at once. You're not replacing anything or trying to restart production. Instead, you're using a compound that influences appetite and glucose outcomes through those receptor pathways. That's the core difference. Some people want that kind of targeted approach. Others prefer something else. It depends on what your programme actually needs.
Most peptides in this lane are positioned around one main pathway. RETATRUTIDE is presented differently: one vial, multi‑pathway targeting (GLP‑1, GIP, and glucagon). That's the headline difference and usually the reason it's selected. For some users, that means fewer separate products in a programme. For others, it simply means they want a single compound with broader coverage, while still keeping the plan controlled and stepwise.
RETATRUTIDE 10mg is generally approached as a longer-format product rather than a "quick run." The product information highlights a roughly weekly rhythm (based on the half‑life referenced on the original page), which naturally suits programmes measured in weeks, not days. People usually build it into a plan where changes can be assessed gradually and adjustments are made in stages. Consistency tends to be the deciding factor here, not intensity.
RETATRUTIDE 10mg is typically chosen by people who want a structured approach and prefer the simplicity of a weekly schedule. It also tends to suit users who care about clear labelling and controlled preparation, since it comes as a lyophilised vial that must be reconstituted before use. It is not a casual add‑on. A clear plan, conservative adjustments, and sensible monitoring make more difference than trying to force outcomes quickly.